Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulinlike growth factor I, serum levels of the high affinity growth hormone-b
β¦ LIBER β¦
Blood serum content of PAMG-1 protein binding insulinlike growth factor 1 (somatomedin C) in patients with diabetes mellitus
β Scribed by S. V. Nazimova; S. S. Obernikhin; M. N. Boltovskaya; N. A. Starovetskaya; E. I. Zaraiskii; B. B. Fuks
- Publisher
- Springer US
- Year
- 1993
- Tongue
- English
- Weight
- 278 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Serum levels of growth hormone-binding p
β
G. Massa; L. Dooms; R. Bouillon; M. Vanderschueren-Lodeweyckx
π
Article
π
1993
π
Springer
π
English
β 577 KB
Relationship between non-enzymatic glyco
β
A. M. Cortizo; P. D. K. Lee; N. V. CΓ©dola; H. Jasper; J. J. Gagliardino
π
Article
π
1998
π
Springer
π
English
β 139 KB
Advanced glycosylation end products (AGE
β
Ma. Eugenia Garay-Sevilla; Laura Eugenia Nava; Juan Manuel Malacara; Kazimierz W
π
Article
π
2000
π
John Wiley and Sons
π
English
β 126 KB
π 1 views
Background Advanced glycosylation end product (AGE) formation is a major mechanism for the development of complications in diabetes, and the possible roles of insulin-like growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) are not clearly established. ## Methods We examined the associati